LTFS
NKTR icon

Ladenburg Thalmann Financial Services’s Nektar Therapeutics NKTR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$704K Buy
2,178
+211
+11% +$61.2K ﹤0.01% 1542
2019
Q3 		$537K Buy
1,967
+354
+22% +$130K ﹤0.01% 1709
2019
Q2 		$861K Buy
1,613
+241
+18% +$121K 0.01% 1332
2019
Q1 		$692K Buy
1,372
+179
+15% +$106K 0.01% 1440
2018
Q4 		$589K Buy
1,193
+38
+3% +$22.9K 0.01% 1412
2018
Q3 		$1.06M Buy
1,155
+459
+66% +$392K 0.01% 1088
2018
Q2 		$1.11M Hold
696
– – 0.01% 1009
2018
Q1 		$1.11M Buy
696
+389
+127% +$501K 0.01% 1009
2017
Q4 		$274K Buy
307
+39
+15% +$23.1K ﹤0.01% 1972
2017
Q3 		$96K Sell
268
-10
-4% -$3.13K ﹤0.01% 2629
2017
Q2 		$82K Sell
278
-27
-9% -$7.8K ﹤0.01% 2640
2017
Q1 		$107K Sell
305
-1,531
-83% -$344K ﹤0.01% 2356
2016
Q4 		$339K Buy
1,836
+1,560
+565% +$317K ﹤0.01% 1474
2016
Q3 		$72K Buy
276
+53
+24% +$13.6K ﹤0.01% 2494
2016
Q2 		$47K Buy
223
+2
+0.9% +$447 ﹤0.01% 2715
2016
Q1 		$46K Sell
221
-92
-29% -$17.7K ﹤0.01% 2657
2015
Q4 		$79K Sell
313
-142
-31% -$29.2K ﹤0.01% 2236
2015
Q3 		$75K Sell
455
-23
-5% -$4.07K ﹤0.01% 2191
2015
Q2 		$90K Hold
478
– – ﹤0.01% 2169
2015
Q1 		$79K Buy
478
+93
+24% +$19.1K ﹤0.01% 2234
2014
Q4 		$89K Buy
385
+12
+3% +$2.56K ﹤0.01% 1966
2014
Q3 		$68K Hold
373
– – ﹤0.01% 1838
2014
Q2 		$72K Hold
373
– – ﹤0.01% 1808
2014
Q1 		$68K Buy
373
+73
+24% +$14.4K ﹤0.01% 1744
2013
Q4 		$51K Buy
300
+60
+25% +$9.68K ﹤0.01% 1899
2013
Q3 		$38K Buy
240
+213
+789% +$39.4K ﹤0.01% 1998
2013
Q2 		$5K Buy
+27
New +$4.14K ﹤0.01% 3048

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NKTR Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Nektar Therapeutics (NKTR) stake by 11% in Q4 2019, buying an estimated $61.2K and bringing the position to 2,178 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

Ladenburg Thalmann Financial Services first reported a position in NKTR in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.11M in Q2 2018. 280 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2,178 shares of Nektar Therapeutics worth $704K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 211 Nektar Therapeutics shares in Q4 2019, an estimated $61.2K.
  • Nektar Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1542 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Nektar Therapeutics position peaked at $1.11M in Q2 2018.
  • 280 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.